Publications Search
This publications portal is a repository of all IOM migration health publications from 2006 to present where IOM was a primary contributor.
Publications include peer-reviewed scientific papers, technical reports, training guides/manuals, policy briefs/discussion papers, factsheets, newsletters, research reviews, conference and poster presentations. These are categorized by topic, author, country/region covered as well as by year, language, and type of publication. The map reflects the countries covered by the publications.
To browse or search: simply use the filter options on the left-hand side. Alternatively, you can enter keyword/s in the search box. Selecting a specific publication will lead to a ‘download’ link or link to the website where the document is housed. Here is the step-by-step guide for your reference.
Migration Health 2022 Impact Overview
Author/s: IOM
This report is an annual overview of activities led and implemented by the Migration Health Division of the International Organization for Migration (IOM) in 2022, in close collaboration with Member States, other United Nations agencies, and partners, to respond to major health needs in the context of human mobility, meet operational challenges and advance understanding of migration health, encourage socioeconomic development through migration, and work towards ensuring respect of the human…
Read moreGovernance for the validation of elimination of mother-to-child transmission of HIV, syphilis and hepatitis B virus: an overview of validation structures and responsibilities at national, regional and global levels
Author/s: World Health Organization
Achieving validation of elimination of mother-to-child transmission (EMTCT) of HIV, syphilis, and hepatitis B virus (HBV) is a tremendous accomplishment, requiring health ministry-led accountability, rigorous data analysis, intensive programme assessment, and multi-level collaboration.
This governance guidance outlines the standardized structures and processes used to validate EMTCT of HIV, syphilis, and HBV at the national, regional, and global levels. Replacing an earlier version…
Read moreMigration Health 2020 Impact Overview
Author/s: IOM
This report is an annual overview of activities led and implemented by the Migration Health Division of the International Organization for Migration (IOM) in 2020, in partnership with Member States, United Nations agencies and other partners in the international community, to respond to the COVID-19 pandemic, meet the operational challenges and advance understanding of migration health, encourage socioeconomic development through migration, and work towards ensuring respect of the human…
Read moreMigration Health Research Bulletin, Issue No. 17
Author/s: IOM
In this issue of the Bulletin, peer-reviewed articles, technical guides, reference books and book chapters which IOM teams have engaged in, ranging from: COVID-19 outbreak preparedness and response in refugee camps, gender-based violence in emergency settings, health system strengthening at borders, and health assessments among forced migrants were profiled. Studies on the elimination of TB and female genital mutilation among migrants and the Ebola outbreak response were also featured. This…
Read moreMigration Health Annual Report 2018
Author/s: IOM
The Migration Health Division of the International Organization for Migration (IOM) acts with Member States, UN agencies and other partners in the international community to meet the operational challenges of migration, advance understanding of migration health issues, encourage socioeconomic development through migration, and work towards ensuring respect of the human dignity and well-being of migrants. This report provides a snapshot of IOM’s health activities in 2018 and presents key…
Read moreMigration Health Research Bulletin, Issue No. 10
Author/s: IOM
A book on IOM’s response to Ebola crisis is profiled. Three reports are featured on the Integrated Biological and Behavioural Surveillance Survey conducted in Somalia and Somaliland. Lastly, three articles are presented which examine (1) undocumented migrants’ access to medical care in Latin American countries; (2) health system responses related to infectious disease prevention and control among refugees and asylum seekers in EU; and (3) challenges migrants and refugees face in accessing …
Read moreInfectious disease testing of UK-bound refugees: a population-based, cross-sectional study
Author/s: Alison Crawshaw, Manish Pareek, John Were, Steffen Schillinger, Olga Gorbacheva, Kolitha Wickramage, Sema Mandal, Valerie Delpech, Noel Gill, Hilary Kirkbride, Dominik Zenner
Background
The UK, like a number of other countries, has a refugee resettlement programme. External factors, such as higher prevalence of infectious diseases in the country of origin and circumstances of travel, are likely to increase the infectious disease risk of refugees, but published data is scarce. The International Organization for Migration carries out and collates data on standardised pre-entry health assessments (HA), including…
Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries
Author/s: Getahun H, Matteelli A, Abubakar I, Aziz MA, Baddeley A, Barreira D, Den Boon S, Borroto Gutierrez SM, Bruchfeld J, Burhan E, Cavalcante S, Cedillos R, Chaisson R, Chee CB, Chesire L, Corbett E, Dara M, Denholm J, de Vries G, Falzon D, Ford N, Gale-Rowe M, Gilpin C, Girardi E, Go UY, Govindasamy D, D Grant A, Grzemska M, Harris R, Horsburgh CR Jr, Ismayilov A, Jaramillo E, Kik S, Kranzer K, Lienhardt C, LoBue P, Lönnroth K, Marks G, Menzies D, Migliori GB, Mosca D, Mukadi YD, Mwinga A, Nelson L, Nishikiori N, Oordt-Speets A, Rangaka MX, Reis A, Rotz L, Sandgren A, Sañé Schepisi M, Schünemann HJ, Sharma SK, Sotgiu G, Stagg HR, Sterling TR, Tayeb T, Uplekar M, van der Werf MJ, Vandevelde W, van Kessel F, van't Hoog A, Varma JK, Vezhnina N, Voniatis C, Vonk Noordegraaf-Schouten M, Weil D, Weyer K, Wilkinson RJ, Yoshiyama T, Zellweger JP, Raviglione M
Abstract
Latent tuberculosis infection (LTBI) is characterized by the presence of immune responses to previously acquired Mycobacterium tuberculosis infection without clinical evidence of active tuberculosis (TB). Here we report evidence-based guidelines from the World Health Organization for a public health approach to the management of LTBI in high-risk individuals in countries with high or middle upper income and TB incidence of <100 per 100 000 per year. The guidelines…
Read more